Core Viewpoint - The Timken Company has applied to the Ontario Securities Commission to cease being a "reporting issuer" in Ontario, Canada, which is the only jurisdiction in Canada where it holds that status [1]. Group 1: Regulatory Changes - If the OSC grants the request, Timken will no longer be required to file certain financial reports and disclosures in Canada, as it already reports these in the United States [2]. - The company will continue to file all financial statements and other continuous disclosure materials required with U.S. regulators and the New York Stock Exchange (NYSE) [2]. Group 2: Shareholder Communication - Canadian shareholders will continue to receive all disclosures provided to U.S. shareholders, in accordance with U.S. securities laws and NYSE rules [3]. Group 3: Company Overview - The Timken Company is a global technology leader in engineered bearings and industrial motion, with $4.6 billion in sales in 2024 and approximately 19,000 employees operating in 45 countries [4].

HONG KONG, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (the “Company” or “Powell Max”), a financial communications services provider headquartered in Hong Kong, today announced its unaudited interim condensed financial results for the six months ended June 30, 2025. Overview: Revenue was HK$23.9 million (US$3.1 million) for the six months ended June 30, 2025, representing an increase of 5.3% for the same period in 2024.Net loss was HK$20.4 million (US$2.6) for the six months ended J ...

Financial Reporting Schedule - Marimekko Corporation will publish its Financial Statements and the Report of the Board of Directors for 2025 in week 13, at the latest [1] - The Financial Statements Bulletin for 2025 is scheduled for Thursday, 12 February 2026, at 8:00 a.m. [4] - Interim Reports for 2026 will be published on the following dates: 13 May 2026 for Q1, 13 August 2026 for H1, and 4 November 2026 for Q3 [4] Annual General Meeting - The Annual General Meeting is planned for Thursday, 16 April 2026, at 2 p.m. [2] - Shareholders can request agenda items for the meeting by sending a written request to the Board of Directors by 15 January 2026 [2] - An announcement regarding the resolutions of the Annual General Meeting will be released after the meeting [2] Company Overview - Marimekko is a Finnish lifestyle design company known for its original prints and colors, with a product portfolio that includes clothing, bags, accessories, and home décor items [3] - In 2024, Marimekko reported net sales of EUR 183 million and a comparable operating profit margin of 17.5 percent [3] - The company operates approximately 170 stores globally and serves customers in 39 countries through its online store, with key markets in Northern Europe, the Asia-Pacific region, and North America [3]

Core Points - Crédit Agricole S.A. has filed Amendment A03 to the 2024 Universal Registration Document with the French Financial Markets Authority (AMF) on August 8th, 2025 [2] - The document is available for public consultation on the company's website under the "URD and Amendments" section [2] Company Information - The filing number for the Amendment A03 is D.25-0137-A03 [2] - Contact information for press inquiries includes Alexandre Barat and Olivier Tassain, with their respective email addresses and phone numbers provided [3]

Financial Reporting Schedule - Orion Corporation will publish its Financial Statement Release for 2025 on Thursday, 12 February 2026 [1] - The Interim Reports and Half-Year Financial Report for 2026 will be published on the following dates: - Interim Report for January-March 2026: Thursday, 23 April 2026 - Half-Year Financial Report for January-June 2026: Friday, 17 July 2026 - Interim Report for January-September 2026: Wednesday, 28 October 2026 [1] Annual General Meeting - The Annual General Meeting is scheduled for Tuesday, 24 March 2026 [2] Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a hundred years of experience, focusing on developing, manufacturing, and marketing human and veterinary pharmaceuticals and active pharmaceutical ingredients [2] - The company has a diverse portfolio that includes proprietary and generic medicines as well as consumer health products, with core therapy areas in oncology and pain [2] - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] - Orion's A and B shares are listed on Nasdaq Helsinki [2]

Core Points - Egide Group has made its 2024 Annual Financial Report available to the public and filed it with the French Financial Markets Authority (AMF) [2][3] - The statutory auditors have expressed reservations regarding the 2024 financial statements, leading to an inability to certify them [3][4] - The report includes the 2024 activity report, consolidated financial statements, annual financial statements, and statutory auditors' reports [7] Financial Calendar - The 2025 Half-Year Revenue will be reported on July 30, 2025 [5] - The Combined General Meeting is scheduled for September 10, 2025 [5] - The 2025 Half-Year Results will be released on October 20, 2025 [5] Company Overview - Egide Group specializes in hermetic packages and heat dissipation solutions for sensitive electronic components, operating in high-tech markets with significant barriers to entry [6][9] - The company has manufacturing bases in France and the United States, positioning itself as a unique player in its market niche [9]